Follow the people · Insider
Vaseem Mahboob
Vaseem Mahboob files insider transactions with the SEC as a chief financial officer of Kestra Medical Technologies (KMTS). We hold 5 disclosed purchases and sales filed since 16 October 2015, 5 of them in the last 90 days.
- Files forKMTS
- Disclosed buys and sells5 in all, 5 in the last 90 days
- Last disclosure11 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 17 July 2025 — 7 August 2026Chief Financial Officer · Kestra Medical Technologies (KMTS)10 Form 4 lines · source: SEC Form 4
- Filed 15 October 2015 — 24 March 2020Chief Financial Officer · Endologix Inc /de/ (ELGX)34 Form 4 lines · source: SEC Form 4
- Filed 30 January 2018 — 4 March 2019Director · Insys Therapeutics (INSY)6 Form 4 lines · source: SEC Form 4
Everything they disclosed
50 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 25,787 shares of Kestra Medical TechnologiesSEC Form 411 August 2026Common Shares · traded 7 August 2026 · filed 11 August 2026
- ▼ sold on the open market 500 shares of Kestra Medical TechnologiesSEC Form 411 August 2026Common Shares · traded 7 August 2026 · filed 11 August 2026
- ▼ sold on the open market 3,080 shares of Kestra Medical TechnologiesSEC Form 46 August 2026Common Shares · traded 4 August 2026 · filed 6 August 2026
- ▼ sold on the open market 3,915 shares of Kestra Medical TechnologiesSEC Form 46 August 2026Common Shares · traded 4 August 2026 · filed 6 August 2026
- ▼ sold on the open market 3,980 shares of Kestra Medical TechnologiesSEC Form 43 August 2026Common Shares · traded 30 July 2026 · filed 3 August 2026
- ▼ sold on the open market 8,817 shares of Kestra Medical TechnologiesSEC Form 43 August 2026Common Shares · traded 31 July 2026 · filed 3 August 2026
- ▼ sold on the open market 5,391 shares of Kestra Medical TechnologiesSEC Form 43 August 2026Common Shares · traded 3 August 2026 · filed 3 August 2026
- was granted 44,118 shares of Kestra Medical TechnologiesSEC Form 417 July 2026Common Shares · traded 15 July 2026 · filed 17 July 2026
- was granted 25,227 shares of Kestra Medical TechnologiesSEC Form 44 June 2026Common Shares · traded 3 June 2026 · filed 4 June 2026
- was granted 22,059 shares of Kestra Medical TechnologiesSEC Form 421 July 2025Common Shares · traded 17 July 2025 · filed 21 July 2025
- was granted 47,010 shares of Endologix Inc /de/SEC Form 426 March 2020Common Stock · traded 24 March 2020 · filed 26 March 2020
- had shares withheld for tax on 3,625 shares of Endologix Inc /de/SEC Form 426 March 2020Common Stock · traded 24 March 2020 · filed 26 March 2020
- was granted 47,010 shares of Endologix Inc /de/SEC Form 42 January 2020Common Stock · traded 30 December 2019 · filed 2 January 2020
- had shares withheld for tax on 3,393 shares of Endologix Inc /de/SEC Form 42 January 2020Common Stock · traded 30 December 2019 · filed 2 January 2020
- was granted 47,010 shares of Endologix Inc /de/SEC Form 417 December 2019Common Stock · traded 13 December 2019 · filed 17 December 2019
- had shares withheld for tax on 2,986 shares of Endologix Inc /de/SEC Form 417 December 2019Common Stock · traded 13 December 2019 · filed 17 December 2019
- returned to the issuer 13,702 shares of Endologix Inc /de/ (a derivative holding)SEC Form 41 October 2019Option to Purchase · traded 27 September 2019 · filed 1 October 2019
- returned to the issuer 11,594 shares of Endologix Inc /de/ (a derivative holding)SEC Form 41 October 2019Option to Purchase · traded 27 September 2019 · filed 1 October 2019
- returned to the issuer 10,999 shares of Endologix Inc /de/ (a derivative holding)SEC Form 41 October 2019Option to Purchase · traded 27 September 2019 · filed 1 October 2019
- was granted 10,959 shares of Endologix Inc /de/ (a derivative holding)SEC Form 41 October 2019Option to Purchase · traded 27 September 2019 · filed 1 October 2019
- was granted 64,800 shares of Endologix Inc /de/ (a derivative holding)SEC Form 46 August 2019Option to Purchase · traded 5 August 2019 · filed 6 August 2019
- was granted 32,400 shares of Endologix Inc /de/SEC Form 46 August 2019Common Stock · traded 5 August 2019 · filed 6 August 2019
- was granted 20,935 shares of Insys Therapeutics (a derivative holding)SEC Form 423 April 2019Employee Stock Option (right to buy) · traded 4 March 2019 · filed 23 April 2019
- was granted 8,083 shares of Insys TherapeuticsSEC Form 423 April 2019Common Stock · traded 4 March 2019 · filed 23 April 2019
- was granted 20,935 shares of Insys Therapeutics (a derivative holding)SEC Form 419 April 2019Employee Stock Option (right to buy) · traded 4 March 2019 · filed 19 April 2019
- was granted 8,083 shares of Insys TherapeuticsSEC Form 419 April 2019Common Stock · traded 4 March 2019 · filed 19 April 2019
- ▲ bought on the open market 15,128 shares of Endologix Inc /de/SEC Form 43 April 2019Common Stock · traded 3 April 2019 · filed 3 April 2019
- was granted 12,500 shares of Endologix Inc /de/SEC Form 43 April 2019Common Stock · traded 3 April 2019 · filed 3 April 2019
- was granted 225,621 shares of Endologix Inc /de/ (a derivative holding)SEC Form 42 January 2019Option to Purchase · traded 30 December 2018 · filed 2 January 2019
- was granted 470,115 shares of Endologix Inc /de/SEC Form 42 January 2019Common Stock · traded 30 December 2018 · filed 2 January 2019
- ▲ bought on the open market 30,000 shares of Endologix Inc /de/SEC Form 420 August 2018Common Shares · traded 16 August 2018 · filed 20 August 2018
- returned to the issuer 28,000 shares of Endologix Inc /de/SEC Form 415 March 2018Common Shares · traded 13 March 2018 · filed 15 March 2018
- was granted 24,000 shares of Insys Therapeutics (a derivative holding)SEC Form 422 February 2018Employee Stock Option (right to buy) · traded 30 January 2018 · filed 22 February 2018
- was granted 6,000 shares of Insys Therapeutics (a derivative holding)SEC Form 422 February 2018Restricted Stock Units · traded 30 January 2018 · filed 22 February 2018
- was granted 33,201 shares of Endologix Inc /de/SEC Form 49 February 2018Common Shares · traded 7 February 2018 · filed 9 February 2018
- had shares withheld for tax on 4,632 shares of Endologix Inc /de/SEC Form 49 February 2018Common Shares · traded 7 February 2018 · filed 9 February 2018
- was granted 25,000 shares of Endologix Inc /de/SEC Form 48 November 2017Common Shares · traded 8 November 2017 · filed 8 November 2017
- was granted 28,000 shares of Endologix Inc /de/SEC Form 42 June 2017Common Shares · traded 31 May 2017 · filed 2 June 2017
- was granted 110,000 shares of Endologix Inc /de/ (a derivative holding)SEC Form 42 June 2017Option to Purchase · traded 31 May 2017 · filed 2 June 2017
- was granted 55,310 shares of Endologix Inc /de/SEC Form 47 April 2017Common Shares · traded 6 April 2017 · filed 7 April 2017
- had shares withheld for tax on 5,184 shares of Endologix Inc /de/SEC Form 47 April 2017Common Shares · traded 6 April 2017 · filed 7 April 2017
- was granted 55,310 shares of Endologix Inc /de/SEC Form 428 February 2017Common Shares · traded 27 February 2017 · filed 28 February 2017
- had shares withheld for tax on 5,222 shares of Endologix Inc /de/SEC Form 428 February 2017Common Shares · traded 27 February 2017 · filed 28 February 2017
- was granted 33,201 shares of Endologix Inc /de/SEC Form 49 February 2017Common Shares · traded 7 February 2017 · filed 9 February 2017
- had shares withheld for tax on 4,919 shares of Endologix Inc /de/SEC Form 49 February 2017Common Shares · traded 7 February 2017 · filed 9 February 2017
- ▲ bought on the open market 20,000 shares of Endologix Inc /de/SEC Form 415 December 2016Common Shares · traded 13 December 2016 · filed 15 December 2016
- was granted 33,201 shares of Endologix Inc /de/SEC Form 417 February 2016Common Shares · traded 4 February 2016 · filed 17 February 2016
- was granted 115,942 shares of Endologix Inc /de/ (a derivative holding)SEC Form 417 February 2016Option to Purchase · traded 4 February 2016 · filed 17 February 2016
- was granted 55,310 shares of Endologix Inc /de/SEC Form 416 October 2015Common Shares · traded 15 October 2015 · filed 16 October 2015
- was granted 137,024 shares of Endologix Inc /de/ (a derivative holding)SEC Form 416 October 2015Option to Purchase · traded 15 October 2015 · filed 16 October 2015
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.